Bioline Rx reported $9.07M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
Bio Path USD 261K 261K Mar/2025
Bioline Rx USD 9.07M 2.31M Mar/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025